Coya Therapeutics, Inc. Common Stock

COYA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

110M

Short interest (May 15)

3.5%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.43%

↓ 3.7%

Available Shares

600K

↓ 33.3%

Price Chart

Company Overview

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001835022

Asset Type: CS

Market Data

Market Cap: $110,952,475

Employees: 8

Status: Active

Short Interest

Current Borrow Fee 0.43%

Range: 0.43% - 0.43%

Available Shares 600K

Range: 600K - 650K

Recent Changes

Fee Change: ↓ 1.0%

Available Change: ↑ 9.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime